ArticleDiabetes, obesity & metabolism2021

Weight-loss response to naltrexone/bupropion is modulated by the Taq1A genetic variant near DRD2 (rs1800497): A pilot study.

Jamie A Mullally et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.